2026年全球人工智慧驅動型診斷放射基因組學設備市場報告

近年來，人工智慧驅動的放射基因組學診斷設備市場發展迅速。預計該市場規模將從2025年的6.2億美元成長到2026年的7.4億美元，複合年成長率（CAGR）為19.2%。過去幾年成長要素包括：慢性病和複雜疾病的盛行率不斷上升、先進診斷影像技術的廣泛應用、精準醫療研究投入的增加、基因測序和分子譜分析應用範圍的擴大，以及對數據驅動型臨床決策解決方案日益成長的需求。

預計未來幾年，人工智慧驅動的放射基因組學診斷設備市場規模將快速成長，到2030年將達到15億美元，複合年成長率（CAGR）為19.5%。預測期內的成長預計將受到以下因素的驅動：對人工智慧驅動的個人化治療計劃解決方案的需求不斷成長；基於雲端的放射基因組學數據分析平台的廣泛應用；基因組學和診斷成像工作流程整合的進步；腫瘤學和神經病學領域精準診斷投資的增加；以及對疾病早期檢測和預測性醫療技術的日益關注。預測期內的關鍵趨勢包括：多模態成像和基因組學整合平台的擴展；對個人化和精準診斷解決方案的需求增加；預測分析在疾病預後和治療反應評估中的應用日益廣泛；自動化放射基因組學資料解讀工具的廣泛應用；以及對診斷工作流程中即時臨床決策支援的日益重視。

精準醫療方法的日益普及預計將推動人工智慧驅動的放射基因組學診斷設備市場的成長。精準醫療方法是指基於個人基因、環境和生活方式差異，最佳化疾病預防、診斷和治療的醫療策略。精準醫療的日益普及主要歸功於基因組數據在先進醫療系統中臨床決策流程的日益整合。人工智慧驅動的放射基因組學診斷設備透過結合醫學影像數據和基因組資料集，支持這一趨勢，從而實現精準的疾病分析、早期診斷和個人化治療方案的發展。例如，根據美國非營利組織個人化醫療聯盟（PMC）2024年2月發布的報告，在截至2023年的連續四年中，美國食品藥物管理局（FDA）新藥認證中超過三分之一是針對個人化療法的。因此，精準醫療方法的日益普及促進並支持了人工智慧驅動的放射基因組學診斷設備市場的成長。

在人工智慧驅動的放射基因組學診斷設備市場中，領先企業正日益關注影像品質評估工具等技術進步，以提高診斷準確性和標準化程度。影像品質評估工具是基於軟體的系統，利用先進的演算法來評估、標準化並確保醫學影像資料的可靠性。例如，2025年6月，總部位於西班牙的醫學影像技術公司Quibim推出了「AI-QUAL」解決方案。此方案利用人工智慧技術自動評估前列腺磁振造影（MRI）的影像質量，賦予標準化的評分，並檢測可能影響診斷結果的偽影。該工具透過確保高品質的影像資料（這對於放射基因組學等下游應用至關重要），從而改善放射科工作流程，並支援更可靠的臨床決策。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球人工智慧驅動的診斷放射基因組學設備市場：吸引力評分與分析
• 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 清單：主要原料、資源和供應商
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章：全球市場趨勢與策略

• 關鍵科技與未來趨勢
  • 人工智慧和自主智慧
  • 生物技術、基因組學和精準醫療
  • 數位化、雲端運算、巨量資料、網路安全
  • 物聯網、智慧基礎設施、互聯生態系統
  • 身臨其境型技術（AR/VR/XR）與數位體驗
• 主要趨勢
  • 擴大多模態成像和基因組學整合平台的應用
  • 對個人化和精準診斷解決方案的需求日益成長
  • 擴大預測分析在評估疾病預後和治療效果的應用。
  • 擴展自動化輻射基因組資料分析工具
  • 人們對診斷工作流程中的即時臨床決策支援越來越感興趣。

第5章 終端用戶產業市場分析

• 醫院和診所
• 診斷影像中心
• 學術和研究機構以及生物樣本庫
• 製藥和生物技術公司以及受託研究機構
• 其他最終用戶

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球人工智慧驅動的診斷放射基因組學設備市場：PESTEL 分析
• 全球人工智慧驅動的診斷放射基因組學設備市場：規模、對比和成長率分析
• 全球人工智慧驅動的診斷放射基因組學設備市場表現：規模和成長，2020-2025年
• 全球人工智慧驅動的診斷放射基因組學設備市場預測：規模和成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

• 按組件
• 硬體、軟體、服務
• 透過成像方式
• 磁振造影、電腦斷層掃描、正子斷層掃描、超音波、X光或乳房X光攝影X光攝影、多模態融合
• 透過使用
• 腫瘤科、神經科、循環系統、感染疾病
• 最終用戶
• 醫院和診所、診斷影像中心、學術和研究機構及生物樣本庫、製藥和生物技術公司及受託研究機構(CRO)、政府和公共衛生項目
• 按類型細分：硬體
• 影像感測器、處理單元、資料儲存系統、網路和連接模組、使用者介面設備
• 按類型細分：軟體
• 輻射基因組學分析軟體、人工智慧診斷演算法、影像處理和校正軟體、資料視覺化和報告工具、機器學習模型管理軟體
• 按類型細分：服務
• 安裝和設定服務、校準和維護服務、培訓和支援服務、資料管理和整合服務、臨床工作流程最佳化服務

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 人工智慧驅動的診斷放射基因組學設備市場：競爭格局和市場佔有率，2024 年
• 人工智慧驅動的診斷放射基因組學設備市場：公司評估矩陣
• 人工智慧驅動的診斷放射基因組學設備市場：公司概況
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Philips Healthcare（Koninklijke Philips NV）
  • GE HealthCare Technologies Inc.
  • Agilent Technologies Inc.

第37章 其他大型企業和創新企業

• Canon Medical Systems Corporation, Tempus AI Inc., Aidoc Medical Ltd., Owkin Inc., SOPHiA GENETICS SA, Lunit Inc., Synaptive Medical Inc., Median Technologies SA, Perspectum Ltd., Quibim SL, Seno Medical Instruments Inc., Ultromics Limited, QMENTA Inc., Imbio LLC, Mirada Medical Limited

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的新創企業

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

• 2030年人工智慧驅動的診斷放射基因組學設備市場：提供新機會的國家
• 2030年人工智慧驅動的診斷放射基因組學設備市場：充滿新機會的細分市場
• 2030年人工智慧驅動的診斷放射基因組學設備市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第42章附錄

Artificial intelligence-powered diagnostic radiogenomics devices are advanced medical systems that combine imaging data with genomic and molecular profiles using artificial intelligence algorithms to detect correlations between radiographic characteristics and underlying genetic expressions, allowing for more accurate disease characterization, risk assessment, and prediction of treatment responses at an individual patient level. These devices are applied in both clinical and research environments to improve early detection, support personalized treatment planning, enhance prognostic evaluation, and enable the advancement of precision medicine approaches by integrating radiology and genomics data analytics.

The primary components of artificial intelligence (AI)-powered diagnostic radiogenomics devices include hardware, software, and services. Hardware comprises the physical imaging equipment and computational infrastructure used to acquire, analyze, and process medical imaging data for radiogenomic evaluation. These devices operate across multiple imaging modalities, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), ultrasound, X-ray or mammography, and multi-modal fusion technologies. Their key applications span oncology, neurology, cardiology, and infectious disease diagnostics. These solutions are widely adopted by hospitals and clinics, diagnostic imaging centers, academic and research institutions, biobanks, pharmaceutical and biotechnology companies, contract research organizations, as well as government and public health programs.

Tariffs are influencing the artificial intelligence (AI)-powered diagnostic radiogenomics devices market by increasing the cost of imported imaging sensors, semiconductor components, computational processing units, and genomic data analysis systems required for advanced diagnostic platforms. This is impacting manufacturing costs and slowing the deployment of precision diagnostic technologies, particularly in regions dependent on imported healthcare and imaging equipment such as Asia-Pacific and Europe. Segments including magnetic resonance imaging systems, artificial intelligence diagnostic algorithms, and radiogenomic analysis software are most affected due to global supply chain dependencies and rising equipment expenses. However, tariffs are also encouraging regional manufacturing expansion, local software development, and investments in domestic healthcare technology ecosystems, thereby creating long-term resilience and innovation opportunities within the market.

The artificial intelligence (AI)-powered diagnostic radiogenomics devices market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI)-powered diagnostic radiogenomics devices market statistics, including artificial intelligence (AI)-powered diagnostic radiogenomics devices industry global market size, regional shares, competitors with a artificial intelligence (AI)-powered diagnostic radiogenomics devices market share, detailed artificial intelligence (AI)-powered diagnostic radiogenomics devices market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-powered diagnostic radiogenomics devices industry. This artificial intelligence (AI)-powered diagnostic radiogenomics devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence (AI)-powered diagnostic radiogenomics devices market size has grown rapidly in recent years. It will grow from $0.62 billion in 2025 to $0.74 billion in 2026 at a compound annual growth rate (CAGR) of 19.2%. The growth in the historic period can be attributed to growing prevalence of chronic and complex diseases, rising adoption of advanced diagnostic imaging technologies, increasing investment in precision medicine research initiatives, expansion of genomic sequencing and molecular profiling applications, growing demand for data-driven clinical decision-making solutions.

The artificial intelligence (AI)-powered diagnostic radiogenomics devices market size is expected to see rapid growth in the next few years. It will grow to $1.5 billion by 2030 at a compound annual growth rate (CAGR) of 19.5%. The growth in the forecast period can be attributed to increasing demand for AI-enabled personalized treatment planning solutions, rising adoption of cloud-based radiogenomic data analytics platforms, growing integration of genomics with diagnostic imaging workflows, increasing investment in oncology and neurology precision diagnostics, rising focus on early disease detection and predictive healthcare technologies. Major trends in the forecast period include increasing adoption of multimodal imaging and genomics integration platforms, growing demand for personalized and precision diagnostic solutions, rising use of predictive analytics for disease prognosis and therapy response assessment, increasing implementation of automated radiogenomic data interpretation tools, growing focus on real-time clinical decision support in diagnostic workflows.

The increasing adoption of precision medicine approaches is expected to propel the growth of the AI-powered diagnostic radiogenomics devices market going forward. Precision medicine approaches refer to medical strategies that tailor disease prevention, diagnosis, and treatment based on individual genetic, environmental, and lifestyle variations. The rising adoption of precision medicine is primarily driven by the expanding integration of genomic data into clinical decision-making processes across advanced healthcare systems. AI-powered diagnostic radiogenomics devices support this trend by combining medical imaging data with genomic datasets to enable precise disease profiling, early diagnosis, and personalized treatment planning. For instance, in February 2024, according to a report by the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, more than one-third of new drug approvals by the U. S. Food and Drug Administration were personalized therapies for four consecutive years through 2023. Therefore, the increasing adoption of precision medicine approaches is contributing to and supporting the growth of the AI-powered diagnostic radiogenomics devices market.

Leading companies operating in the AI-powered diagnostic radiogenomics devices market are increasingly focusing on technological advancements such as imaging quality assessment tools to enhance diagnostic accuracy and standardization. An imaging quality assessment tool is a software-based system that uses advanced algorithms to evaluate, standardize, and ensure the reliability of medical imaging data. For example, in June 2025, Quibim, a Spain-based medical imaging technology company, launched AI-QUAL, a solution that applies artificial intelligence to automatically assess prostate magnetic resonance imaging quality, assign standardized scores, and detect artifacts that may compromise diagnostic outcomes. The tool enhances radiology workflows and supports more reliable clinical decision-making by ensuring high-quality imaging data, which is essential for downstream applications such as radiogenomics.

In March 2026, RadNet acquired Gleamer for $270 million. The acquisition is intended to strengthen RadNet's artificial intelligence capabilities in radiology by incorporating Gleamer's diagnostic technologies and global software-as-a-service platform across X-ray, mammography, CT, and MRI imaging. This integration is expected to improve imaging workflows related to screening, detection, and diagnostic interpretation for conditions including cancer, musculoskeletal disorders, and neurodegenerative diseases.

Major companies operating in the artificial intelligence (ai)-powered diagnostic radiogenomics devices market are Thermo Fisher Scientific Inc., Siemens Healthineers AG, Philips Healthcare (Koninklijke Philips N. V. ), GE HealthCare Technologies Inc., Agilent Technologies Inc., Canon Medical Systems Corporation, Tempus AI Inc., Aidoc Medical Ltd., Owkin Inc., SOPHiA GENETICS SA, Lunit Inc., Synaptive Medical Inc., Median Technologies SA, Perspectum Ltd., Quibim S. L., Seno Medical Instruments Inc., Ultromics Limited, QMENTA Inc., Imbio LLC, Mirada Medical Limited, VUNO Inc., Radiomics. bio Inc., Qlucore AB, CureMetrix Inc.

North America was the largest region in the artificial intelligence (AI)-powered diagnostic radiogenomics devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-powered diagnostic radiogenomics devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the artificial intelligence (AI)-powered diagnostic radiogenomics devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI)-powered diagnostic radiogenomics devices market consists of sales of radiogenomic data integration platforms, artificial intelligence-based image-genomic correlation software, predictive analytics engines for genotype-phenotype mapping, cloud-enabled radiogenomics processing systems,, genomic annotation and imaging biomarker extraction tools, and interoperable radiology-genomics data management systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses artificial intelligence (ai)-powered diagnostic radiogenomics devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai)-powered diagnostic radiogenomics devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai)-powered diagnostic radiogenomics devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Component: Hardware; Software; Services
• 2) By Imaging Modality: Magnetic Resonance Imaging; Computed Tomography; Positron Emission Tomography; Ultrasound; X-Ray Or Mammography; Multi-Modal Fusion
• 3) By Application: Oncology; Neurology; Cardiology; Infectious Diseases
• 4) By End User: Hospitals And Clinics; Diagnostic Imaging Centers; Academic And Research Institutes And Biobanks; Pharmaceutical And Biotechnology Companies And Contract Research Organizations; Government And Public Health Programs
• Subsegments:
• 1) By Hardware: Imaging Sensors; Computational Processing Units; Data Storage Systems; Networking And Connectivity Modules; User Interface Devices
• 2) By Software: Radiogenomic Analysis Software; Artificial Intelligence Diagnostic Algorithms; Image Processing And Enhancement Software; Data Visualization And Reporting Tools; Machine Learning Model Management Software
• 3) By Services: Installation And Setup Services; Calibration And Maintenance Services; Training And Support Services; Data Management And Integration Services; Clinical Workflow Optimization Services
• Companies Mentioned: Thermo Fisher Scientific Inc.; Siemens Healthineers AG; Philips Healthcare (Koninklijke Philips N.V.); GE HealthCare Technologies Inc.; Agilent Technologies Inc.; Canon Medical Systems Corporation; Tempus AI Inc.; Aidoc Medical Ltd.; Owkin Inc.; SOPHiA GENETICS SA; Lunit Inc.; Synaptive Medical Inc.; Median Technologies SA; Perspectum Ltd.; Quibim S.L.; Seno Medical Instruments Inc.; Ultromics Limited; QMENTA Inc.; Imbio LLC; Mirada Medical Limited; VUNO Inc.; Radiomics.bio Inc.; Qlucore AB; CureMetrix Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Biotechnology, Genomics & Precision Medicine
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Immersive Technologies (AR/VR/XR) & Digital Experiences
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Multimodal Imaging And Genomics Integration Platforms
  • 4.2.2 Growing Demand For Personalized And Precision Diagnostic Solutions
  • 4.2.3 Rising Use Of Predictive Analytics For Disease Prognosis And Therapy Response Assessment
  • 4.2.4 Increasing Implementation Of Automated Radiogenomic Data Interpretation Tools
  • 4.2.5 Growing Focus On Real-Time Clinical Decision Support In Diagnostic Workflows

5. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Analysis Of End Use Industries

• 5.1 Hospitals And Clinics
• 5.2 Diagnostic Imaging Centers
• 5.3 Academic And Research Institutes And Biobanks
• 5.4 Pharmaceutical And Biotechnology Companies And Contract Research Organizations
• 5.5 Other End Users

6. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Segmentation

• 9.1. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hardware, Software, Services
• 9.2. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Magnetic Resonance Imaging, Computed Tomography, Positron Emission Tomography, Ultrasound, X-Ray Or Mammography, Multi-Modal Fusion
• 9.3. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oncology, Neurology, Cardiology, Infectious Diseases
• 9.4. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals And Clinics, Diagnostic Imaging Centers, Academic And Research Institutes And Biobanks, Pharmaceutical And Biotechnology Companies And Contract Research Organizations, Government And Public Health Programs
• 9.5. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Imaging Sensors, Computational Processing Units, Data Storage Systems, Networking And Connectivity Modules, User Interface Devices
• 9.6. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Radiogenomic Analysis Software, Artificial Intelligence Diagnostic Algorithms, Image Processing And Enhancement Software, Data Visualization And Reporting Tools, Machine Learning Model Management Software
• 9.7. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Installation And Setup Services, Calibration And Maintenance Services, Training And Support Services, Data Management And Integration Services, Clinical Workflow Optimization Services

10. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Regional And Country Analysis

• 10.1. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 11.1. Asia-Pacific Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 12.1. China Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 13.1. India Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 14.1. Japan Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 15.1. Australia Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 16.1. Indonesia Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 17.1. South Korea Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 18.1. Taiwan Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 19.1. South East Asia Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 20.1. Western Europe Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 21.1. UK Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 22.1. Germany Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 23.1. France Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 24.1. Italy Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 25.1. Spain Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 26.1. Eastern Europe Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 27.1. Russia Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 28.1. North America Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 29.1. USA Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 30.1. Canada Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 31.1. South America Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 32.1. Brazil Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 33.1. Middle East Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 34.1. Africa Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Regulatory and Investment Landscape

36. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Competitive Landscape And Company Profiles

• 36.1. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Company Profiles
  • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Philips Healthcare (Koninklijke Philips N.V.) Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Other Major And Innovative Companies

• Canon Medical Systems Corporation, Tempus AI Inc., Aidoc Medical Ltd., Owkin Inc., SOPHiA GENETICS SA, Lunit Inc., Synaptive Medical Inc., Median Technologies SA, Perspectum Ltd., Quibim S.L., Seno Medical Instruments Inc., Ultromics Limited, QMENTA Inc., Imbio LLC, Mirada Medical Limited

38. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

41. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market High Potential Countries, Segments and Strategies

• 41.1 Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market In 2030 - Countries Offering Most New Opportunities
• 41.2 Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market In 2030 - Segments Offering Most New Opportunities
• 41.3 Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer